May. 5 at 10:04 AM
WATCHLIST MAY 05 2025
$OABI VERAXA Biotech Joins Forces with OmniAb to Develop Novel Bispecific Antibody Drug Conjugate Targeting Solid Tumors
$AAPL Apple To Split iPhone Launches Starting 2026, Foldable Model May Debut With iPhone 18 Pro: Report
$VIAV UBS Maintains Neutral on Viavi Solutions, Lowers Price Target to
$11
$CSTL Castle Biosciences To Share New Data at DDW 2025 Highlighting TissueCypher Test's Ability To Identify Patients At Increased Risk For Developing Esophageal Cancer
$NVO Novo Nordisk Announces The FDA Accepts Filing Application For Oral Semaglutide 25mg, Which If Approved, Would Be The First Oral GLP-1 Treatment For Obesity